Is early diagnosis of pulmonary arterial hypertension possible in inflammatory rheumatic diseases? Experience from a single center in Turkey.
暂无分享,去创建一个
A. Oto | A. Akdoğan | L. Tokgözoğlu | K. Aytemir | L. Kılıç | I. Ertenli | L. Çöplü | S. Okutucu | B. Evranos | B. Kaya | M. Çalgüneri
[1] H. Heinzl,et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study , 2013, Annals of the rheumatic diseases.
[2] M. Humbert,et al. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. , 2013, Arthritis and rheumatism.
[3] C. Denton,et al. Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension. , 2013, Arthritis and rheumatism.
[4] D. Liew,et al. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study , 2012, Arthritis Research & Therapy.
[5] V. Steen,et al. Practical approach to screening for scleroderma‐associated pulmonary arterial hypertension , 2012, Arthritis care & research.
[6] M. Mayes,et al. Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry , 2012, Annals of the rheumatic diseases.
[7] J. S. Muhammad,et al. Pulmonary Hypertension in Systemic Sclerosis , 2011 .
[8] R. Benza,et al. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective. , 2011, Journal of the American College of Cardiology.
[9] S. Harari,et al. Pleural and pulmonary involvement in systemic lupus erythematosus. , 2011, Presse medicale.
[10] J. Gibbs. Treating pulmonary arterial hypertension: is it worth it? , 2010, Heart.
[11] G. Giannakoulas,et al. Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension. , 2010, Seminars in arthritis and rheumatism.
[12] G. Filippatos,et al. Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .
[13] M. Humbert,et al. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. , 2009, Arthritis and rheumatism.
[14] B. Dijkmans,et al. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy , 2009, European Respiratory Journal.
[15] R. Landewé,et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) , 2009, Annals of the rheumatic diseases.
[16] S. Wakounig,et al. Risk factors for chronic thromboembolic pulmonary hypertension , 2008, European Respiratory Journal.
[17] A. Kahan,et al. Cardiac complications of systemic sclerosis. , 2006, Rheumatology.
[18] A. Paladini,et al. Functional assessment of patients with systemic sclerosis by the use of 'Six-minutes-walking-test'. , 2009, La Clinica terapeutica.
[19] G. Simonneau,et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial , 2008, The Lancet.
[20] M. Humbert,et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. , 2008, Arthritis and rheumatism.
[21] G. Simonneau,et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. , 2008, American journal of respiratory and critical care medicine.
[22] T. Medsger,et al. Changes in causes of death in systemic sclerosis, 1972–2002 , 2007, Annals of the rheumatic diseases.
[23] K. Lewis. Pulmonary Arterial Hypertension in France: Results from a National Registry , 2007 .
[24] J. Loscalzo,et al. Pulmonary arterial hypertension. , 2004, Annals of medicine.
[25] M. Humbert,et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. , 2005, Arthritis and rheumatism.
[26] J. Lima,et al. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). , 2005, Arthritis and rheumatism.
[27] Horst Olschewski,et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. , 2004, European heart journal.
[28] R. Moots,et al. Screening for pulmonary arterial hypertension in systemic sclerosis. , 2004, Rheumatology.
[29] P. Carreira. Pulmonary hypertension in autoimmune rheumatic diseases. , 2004, Autoimmunity reviews.
[30] C. Denton,et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach , 2003, Annals of the rheumatic diseases.
[31] T. Medsger,et al. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. , 2003, Arthritis and rheumatism.
[32] A. Wells,et al. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. , 1997, British journal of rheumatology.
[33] A. Chaouat,et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. , 1995, Chest.